BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding Z, He Y, Fu Y, Zhu N, Zhao M, Song Y, Huang X, Chen S, Yang Y, Zhang C, Hu Q, Ni Y, Ding L. CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint. Front Oncol 2021;11:687430. [PMID: 34211854 DOI: 10.3389/fonc.2021.687430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao M, He Y, Zhu N, Song Y, Hu Q, Wang Z, Ni Y, Ding L. IL-33/ST2 signaling promotes constitutive and inductive PD-L1 expression and immune escape in oral squamous cell carcinoma. Br J Cancer 2023;128:833-43. [PMID: 36463324 DOI: 10.1038/s41416-022-02090-0] [Reference Citation Analysis]
2 Duan Y, Chen R, Huang Y, Meng X, Chen J, Liao C, Tang Y, Zhou C, Gao X, Sun J. Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy. Cell Mol Life Sci 2021;79:14. [PMID: 34966954 DOI: 10.1007/s00018-021-04089-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Sun Y, Wang S, Zhang X, Wu Z, Li Z, Ding Z, Huang X, Chen S, Jing Y, Zhang X, Ding L, Song Y, Sun G, Ni Y. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma. Biomolecules 2021;11:1842. [DOI: 10.3390/biom11121842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Louis W, Guorong L, Anne-emmanuelle B, Claude L. Flow cytometry potential applications in characterizing solid tumors main phenotype, heterogeneity and circulating cells. Arch Pathol Clin Res 2021;5:010-015. [DOI: 10.29328/journal.apcr.1001022] [Reference Citation Analysis]